Drugs for all: the future of global AIDS treatment.
I am interested in the arts of government that accompany economic globalization and in the remaking of populations as market segments (specifically therapeutic markets). Using the Brazilian response to AIDS as an ethnographic baseline, I examine the systemic relations between pharmaceutical commerce and public health care and the value systems that underscore global AIDS treatment initiatives. The pharmaceuticalization of governance and citizenship, obviously efficacious in the treatment of AIDS, nonetheless crystallizes new inequalities.
Biehl
João
J
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000191:economics; D044966:Anti-Retroviral Agents / Q000191:economics* / Q000627:therapeutic use; D001938:Brazil; D004345:Drug Industry / Q000191:economics; D014943:Global Health; D006291:Health Policy / Q000191:economics; D054625:Healthcare Disparities; D006801:Humans; D015980:Public Health Practice; D014481:United States
D044966:Anti-Retroviral Agents